| Pharmaceutical active ingredients: |
| Granisetron Hydrochloride |
| Available forms, composition and doses of Kevatril: |
| N / A |
| Kevatril medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA02 - Granisetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Roche |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Granisetron | Granisetron Hydrochloride | Taro Pharmaceutical Industries |
| Granisetron | Granisetron Hydrochloride | Teva |
| Granisetron | Granisetron Hydrochloride | Watson Pharmaceuticals |
| Granisetron | Granisetron Hydrochloride | Wockhardt |
| Granisteron | Granisetron Hydrochloride | Hikma Pharmaceuticals |
| Kytril | Granisetron Hydrochloride | Roche; DKSH; Genentech; GlaxoSmithKline; Mayne Pharma; Zuellig Pharma |
| Rigmoz | Granisetron Hydrochloride | Elvetium |
| Setron | Granisetron Hydrochloride | Perrigo |
| Cadigran | Granisetron; Granisetron Hydrochloride | Cadila |
| Granisol | Granisetron; Granisetron Hydrochloride | Intra Labs India |